Detection of cancer‐associated cachexia in lung cancer patients using whole‐body [18F]FDG‐PET/CT imaging: A multi‐centre study
Abstract Background Cancer‐associated cachexia (CAC) is a metabolic syndrome contributing to therapy resistance and mortality in lung cancer patients (LCP). CAC is typically defined using clinical non‐imaging criteria. Given the metabolic underpinnings of CAC and the ability of [18F]fluoro‐2‐deoxy‐D...
Saved in:
| Main Authors: | Daria Ferrara, Elisabetta M. Abenavoli, Thomas Beyer, Stefan Gruenert, Marcus Hacker, Swen Hesse, Lukas Hofmann, Smilla Pusitz, Michael Rullmann, Osama Sabri, Roberto Sciagrà, Lalith Kumar Shiyam Sundar, Anke Tönjes, Hubert Wirtz, Josef Yu, Armin Frille |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.13571 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cancer Cachexia: Innovations in Pharmacotherapy for Terminal-Stage Patients - Review of the latest reports
by: Kinga Witowska, et al.
Published: (2025-01-01) -
Early administration of anamorelin improves cancer cachexia in gastrointestinal cancer patients: an observational study
by: Toshihiko Matsumoto, et al.
Published: (2024-12-01) -
Predictive value of bioelectrical impedance analysis and CT in cancer cachexia
by: WANG Yu, et al.
Published: (2024-04-01) -
Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study
by: Mmadili N. Ilozumba, et al.
Published: (2024-11-01) -
Tocilizumab in combination with corticosteroids: potential for managing cancer cachexia with systemic hyperinflammation
by: Ping Chen, et al.
Published: (2024-12-01)